Mercury activates phospholipase A2 and induces formation of arachidonic acid metabolites in vascular endothelial cells

Toxicology Mechanisms and Methods

Volumn 17, Issue 9, 2007, Pages 541-557

  Mazerik, Jessica N ^a   Mikkilineni, Himabindu ^a   Kuppusamy, Vivek A ^a   Steinhour, Emily ^a   Peltz, Alon ^a   Marsh, Clay B ^a   Kuppusamy, Periannan ^a   Parinandi, Narasimham L ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Arachidonic Acid; Isoprostane; Lipid Signaling; Mercury; Phospholipase A 2; PLA2; Prostaglandin; Thromboxane B2; Vascular Endothelial Cells

Indexed keywords

8 ISOPROSTANE; ARACHIDONIC ACID; ARACHIDONYL TRIFLUOROMETHYL KETONE; CALCIUM; CALCIUM CHELATING AGENT; LIGAND; MEMBRANE PHOSPHOLIPID; MERCURY CHLORIDE; METAL CHELATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN; THIOL DERIVATIVE; THROMBOXANE B2; TRITIUM; TRYPAN BLUE;

ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; EXPOSURE; LIQUID SCINTILLATION COUNTING; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SIGNAL TRANSDUCTION;

BOVINAE;

EID: 36749103191     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510701380505     Document Type: Article

References (47)

1. Antoniotti, S., Fiorio, P. A., Pregnolato, S., Mottola, A., Lovisolo, D., and Munaron, L. 2003. Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: a pharmacological approach. J. Cell Physiol. 197(3):370-378.
2. Aschner, M. 2000. Astrocyte swelling, phospholipase A2, glutathione and glutamate: interactions in methylmercury-induced neurotoxicity. Cell Mol Biol. (Noisy-le-grande) 46(4):843-854.
3. Balsinde, J., Winstead, M. V., and Dennis, E. A. 2000. Phospholipase A2 regulation of arachidonic acid mobilization. FEBS Lett 531:2-6.
4. Blanusa, M., Varnai, V. M., Piasek, M., and Kostial, K. 2005. Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr. Med. Chem. 12(23):2771-2794.
5. Boening, D. W. 2000. Ecological effects, transport, and fate of mercury: a general review. Chemosphere 40:1335-1351.
6. Boffetta, P., Sallsten, G., Garcia-Gomez, M., Pompe-Kirn, V., Zaridze, D., Bulbulyan, M., Caballero, J. D., Ceccarelli, F., Kobal, A. B., and Merler, E. 2001. Mortality from cardiovascular disease and exposure to inorganic mercury. Occup. Environ. Med. 58:461-466.
7. Bogatcheva, N. V., Sergeeva, M. G., Dudek, S. M., and Verin, A. D. 2005. Arachidonic acid cascade in endothelial pathobiology. Microvasc. Res. 69:107-127.
8. Chakraborti, S. 2003. Phospholipase A2 isoforms: a perspective. Cell Signal 15:637-665.
9. Chan, H. M., and Egeland, G. M. 2004. Fish consumption, mercury exposure, and heart disease. Nutr. Rev. 62:68-72.
10. Clarkson, T. W. 2002. The three modern faces of mercury. Environ. Health Perspect. 110:11-23.
11. Clarkson, T. W., Magos, L., and Myers, G. J. 2003. The toxicology of mercury-current exposures and clinical manifestations. N. Engl. J. Med. 349:1731-1737.
12. Dennis, E. A., Rhee, S. G., Billah, M. M., and Hannun, Y. A. 1991. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J 5:2068-2077.
13. Divecha, N., and Irvine, R. F. 1995. Phospholipid signaling. Cell 80:269-278.
14. Dopp, E., Hartman, L. M., Florea, A. M., Rettenmeier, A. W., and Hirner, A. V. 2004. Environmental distribution, analysis, and toxicity of organometal (loid) compounds. Crit. Rev. Toxicol. 34:301-333.
15. Egermayer, P. 2000. Epidemics of vascular toxicity and pulmonary hypertension: what can be learned?. J. Intern. Med. 247:11-17.
16. Hagele, T. J., Mazerik, J. N., Gregory, A., Kaufman, B., Magalang, U., Kuppusamy, M., Marsh, C. B., Kuppusamy, P., and Parinandi, N. L. 2006. Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. Int. J. Toxicol. 26(1): 57-69.
17. ++ and heavy metals in NG108-15 cells. J. Pharmacol. Exp. Ther. 266(3):1626-1635.
18. Hurt-Camejo, E., Camejo, G., Peilot, H., Oorni, K., and Kovanen, P. 2001. Phospholipase A2 in vascular disease. Circ. Res. 89:298-304.
19. Kang, M. S., Jeong, J. Y., Seo, J. H., Jeon, H. J., Jung, K. M., Chin, M. R., Moon, C. K., Bonventre, J. V., Jung, S. Y., and Kim, D. K. 2006. Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholinespecific phospholipase C. Toxicol. Appl. Pharmacol. 216(2):206-215.
20. Kim, D. S., Lee, E. H., Yu, S. D., Cha, J. H,., and Ahn, S. C. 2005. Heavy metal as risk factor of cardiovascular disease - an analysis of blood lead and urinary mercury. J. Prev. Med. Pub. Health 38:401-407.
21. Kostka, B. 1991. Toxicity of mercury compounds as a possible risk for cardiovascular diseases. Br. J. Ind. Med. 48:845.
22. Kuehn, B. 2005. Medical Groups Sue EPA Over Mercury Rule. JAMA. 294:415-416.
23. Lambert, I. H., Pedersen, S. F., and Poulsen, K. A. 2006. Activation of PLA2 isoforms by cell swelling and ischemia/hypoxia. Acta Physiol. 187:75-85.
24. Landmark, K., and Aursnes, I. 2004. Mercury, fish, fish oil and the risk of cardiovascular disease. Tidsskr. Nor. Laegeforen. 124:198-200.
25. Limke, T. L., Bearss, J. J., and Atchison, W. D. 2004. Acute exposure to methylmercury causes Ca2 +dysregulation and neuronal death in rat cerebellar granule cells through an M3 muscarinic receptor-linked pathway. Toxicol. Sci. 80:60-68.
26. 2 on arachidonic acid release induced by reactive oxygen species. Arch. Biochem. Biophys. 392(2):257-262.
27. Marty, M. S., and Atchison, W. D. 1998. Elevations of intracellular Ca2+ as a probable contributor to decreased viability in cerebellar granule cells following acute exposure to methylmercury. Toxicol. Appl. Pharmacol. 150(1):98-105.
28. Mutter, J., Naumann, J., Sadaghiani, C., Walach, H., and Drasch, G. 2004. Amalgam studies disregarding basic principles of mercury toxicity. Int. J. Hyg. Environ. Health 207:391-397.
29. Nash, R. A. 2005. Metals in medicine. Altern. Ther. Health Med. 11:18-25.
30. Nigam, S., and Schewe, T. 2000. Phospholipase A2s and lipid peroxidation. Biochim. Biophys. Acta 1488:167-181.
31. Parinandi, N. L., Scribner, W. M., Vepa, S., Shi, S., and Natarajan, V. 1999. Phospholipase D activation in endothelial cells is redox sensitive. Antioxid. Redox. Signal 1(2):193-210.
32. Phillis, J. W., and O'Regan, M. H. 2003. The role of phospholipases, cyclooxygenases, and lipoxygenases in cerebral ischemic/traumatic injuries. Crit. Rev. Neurobiol. 15:61-90.
33. Pleva, J. 1994. Dental mercury - a public health hazard. Rev. Environ. Health 10:1-27.
34. Reiss, A. B., and Edelman, S. D. 2006. Recent insights into the role of prostanoids in atherosclerotic vascular disease. Curr. Vasc. Pharmacol. 4:395-408.
35. 2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J. Biol. Chem. 269(22):15619-15624.
36. Sarafian, T. A. 1993. Methylmercury increases intracellular Ca2+ and inositol phosphate levels in cultured cerebellar granule neurons. J. Neurochem. 61(2):648-657.
37. Sarkar, B. A. 2005. Mercury in the environment: effect on health and reproduction. Rev. Environ. Health 20:39-56.
38. Shanker, G., and Aschner, M. 2001. Identification and characterization of uptake systems for cystine and cysteine ion cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport. J. Neurosci. Res. 66:998-1002.
39. Shanker, G., Mutkus, L. A., Walker, S. J., and Aschner, M. 2002. Methylmercury enhances arachidonic acid and cytosolic phospholipase A2 expression in primary cultures of neonatal astrocytes. Mol. Brain Res. 106:1-11.
40. Shanker, G., Syversen, T., and Aschner, M. 2003. Astrocyte-mediated methylmercury Neurotoxicity. Biol. Trace Elem. Res. 95(1):1-10.
41. Shanker, G., Syversen, T., Aschner, J. L., and Aschner, M. 2005. Modulatory effect of glutathione status and antioxidants on methylmercury- induced free radical formation in primary cultures of cerebral astrocytes. Mol. Brain Res. 137:11-22.
42. Valko, M., Morris, H., and Cronin, M. T. 2005. Metals, toxicity and oxidative stress. Curr. Med. Chem. 12(10):1161-1208.
43. Varadharaj, S., Steinhour, E., Hunter, M. G., Watkins, T., Baran, C. P., Magalang, U., Kuppusamy, P., Zwier, J. L., Marsh, C. B., Natarajan, V., and Parinandi, N. L. 2006. Vitamin C-induced activation of phospholipase D in lung microvascular endothelial cells: regulation by MAP kinases. Cell Signal 18:1396-1407.
44. 2 stimulation by methylmercury in neuron culture. J. Neurochem. 62:705-714.
45. Wakita, Y. 1987. Hypertension induced by methylmercury in rats. Toxicol. Appl. Pharmacol. 89:144-147.
46. 2. Free Radic. Biol. Med. 34(12):1531-1543.
47. Yoshizawa, K., Rimm, E. B., Morris, J. S., Spate, V. L., Hsieh, C. C., Spiegelman, D., Stampfer, M. J., and Willett, W. C. 2002. Mercury and the risk of coronary heart disease in men. N. Engl. J. Med. 347:1755-1760.